Authors:
Treon, SP
Agus, TB
Link, B
Rodrigues, G
Molina, A
Lacy, MQ
Fisher, DC
Emmanouilides, M
Richards, AI
Clark, B
Lucas, MS
Schlossman, R
Schenkein, D
Lin, B
Kimby, E
Anderson, KC
Byrd, JC
Citation: Sp. Treon et al., CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia, J IMMUNOTH, 24(3), 2001, pp. 272-279
Authors:
Byrd, JC
Murphy, T
Howard, RS
Lucas, MS
Goodrich, A
Park, K
Pearson, M
Waselenko, JK
Ling, G
Grever, MR
Grillo-Lopez, AJ
Rosenberg, J
Kunkel, L
Flinn, IW
Citation: Jc. Byrd et al., Rituximab using a thrice weekly dosing schedule in B-Cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity, J CL ONCOL, 19(8), 2001, pp. 2153-2164
Citation: Ms. Lucas et al., Contextual themes in career decision making of female clients who indicatedepression, J COUNS DEV, 78(3), 2000, pp. 316-325
Authors:
Byrd, JC
White, CA
Link, B
Lucas, MS
Velasquez, WS
Rosenberg, J
Grillo-Lopez, AJ
Citation: Jc. Byrd et al., Rituximab therapy in Waldenstrom's macroglobulinemia: Preliminary evidenceof clinical activity, ANN ONCOL, 10(12), 1999, pp. 1525-1527